SCHEMBL5771814

SCHEMBL5771814

CCOP(=O)(Cc1ccc(NC(=O)CCc2cnoc2-c2cc(Cl)cc(Cl)c2)cc1)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.40
MAPK1 P28482 5/20 0.40
MEN1 O00255 4/20 0.40
LMNA P02545 4/20 0.40
KMT2A Q03164 4/20 0.40
GLA P06280 1/20 0.40
LTA4H P09960 1/20 0.39
EPHX2 P34913 1/20 0.39
BTK Q06187 2/20 0.38
ENTPD1 P49961 1/20 0.38
PTK2 Q05397 1/20 0.36
ENPP2 Q13822 1/20 0.36
DGAT2 Q96PD7 1/20 0.36
ENTPD2 Q9Y5L3 1/20 0.35
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TP53 P04637 1/20 0.35
HDAC1 Q13547 3/20 0.34
HDAC2 Q92769 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5777014 0.92 MEN1 (0.46) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5775980 0.91 MEN1 (0.37) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5772702 0.89 MEN1 (0.39) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5771726 0.88 LTA4H (0.46) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5773241 0.88 BTK (0.39) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5772828 0.87 LTA4H (0.48) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5776568 0.87 LMNA (0.38) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5773311 0.87 BTK (0.38) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5777451 0.86 MEN1 (0.41) MAPTMAPK1MEN1LMNAKMT2A
SCHEMBL5771359 0.86 MEN1 (0.40) MAPTMAPK1MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MAPT 4701/4885MAPK1 1148/4885MEN1 2811/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MAPT 4763/4885MAPK1 485/4885MEN1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.